Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|URCC-16070||NCORP-University of Rochester Cancer Center||Treatment of Refractory Nausea||Cancer Prevention and Control CIRB||Available to Open|
|URCC-16092||NCORP-University of Rochester Cancer Center||Phase II Study of Low-Dose Ibuprofen for Cognitive Problems in Patients with Cancer||Cancer Prevention and Control CIRB||Available to Open|
|URCC-18004CD||NCORP-University of Rochester Cancer Center||Understanding the Impact of Drug Shortages on Oncology Care Delivery||Cancer Prevention and Control CIRB||Completed|
|URCC-18007||NCORP-University of Rochester Cancer Center||Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue||Cancer Prevention and Control CIRB||Available to Open|
|URCC-18110CD||NCORP-University of Rochester Cancer Center||Implementing Palliative Care: Learning Collaborative vs. Technical Assistance||Cancer Prevention and Control CIRB||Available to Open|
|URCC-19085||NCORP-University of Rochester Cancer Center||Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial||Cancer Prevention and Control CIRB||Available to Open|
|UWI2014-03-01||CLO-University of Wisconsin||A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer||Cancer Prevention and Control CIRB||Available to Open|
|UWI2015-05-01||CLO-University of Wisconsin||Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect||Cancer Prevention and Control CIRB||Available to Open|
|UWI2016-07-01||CLO-University of Wisconsin||Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment||Cancer Prevention and Control CIRB||Available to Open|
|UWI2016-08-01||CLO-University of Wisconsin||Pilot Study of Daily Exemestane in Women with Complex Atypical Hyperplasia of the Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer||Cancer Prevention and Control CIRB||Available to Open|